[TNM肺癌分类第九版的介绍]
1Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
Zhonghua zhong liu za zhi [Chinese journal of oncology]
|March 18, 2024
概括
肺癌TNM分期系统更新至第9版,自2024年1月起生效. 这一修订包含了新的预后因素,以改善肺癌分类和患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 医学诊断 医学诊断 医学诊断
- 癌症研究 癌症研究
背景情况:
- 肺癌是全球癌症死亡的主要原因之一.
- 向治疗和检查点抑制剂改善了晚期肺癌的治疗结果.
- 在肺癌预后和治疗决策中,TNM分期系统至关重要.
研究的目的:
- 审查肺癌TNM分期系统的历史,数据来源和局限性.
- 讨论即将发布的第九版TNM肺癌分类.
- 突出更新的预后因素对肺癌分期的影响.
主要方法:
- 对TNM分阶段系统历史发展的回顾.
- 对数据资源的分析,为TNM分类更新提供信息.
- 讨论TNM分阶段系统固有的局限性.
主要成果:
- 国际肺癌研究协会 (IASLC) 在2023年9月发布了TNM分类的第9版.
- 第九版将于2024年1月通过,反映了肺癌知识的进步.
- 更新旨在提高肺癌预后和治疗指导的准确性.
结论:
- 根据对肺癌预后因素的知识的积累,TNM分期系统继续发展.
- 第九版代表了肺癌分类国际标准的重大更新.
- 了解TNM分期系统及其更新对于临床医生和研究人员在肺癌管理方面至关重要.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


